Send Albanian Hedge Fund Jew Martin Shkreli To Israel ...
politicalandsciencerhymes.blogspot.com/.../send-albanian-hedge-fund-je...
Sep 22, 2015 - Send Albanian Hedge Fund Jew Martin Shkreli To Israel After Confiscating His Blood Money Drug Profits Or Droip Him Out Of An Airplane In ..CEO Who Raised AIDS Drug from $13 to $750 Started with ...
ringoffireradio.com/.../ceo-who-raised-aids-drug-from-13-to-750-started...
Sep 21, 2015 - Martin Shkreli, the 32-year-old CEO of Turning Pharmaceuticals who raised ... to $750 started his career with CNBC's Mad Money Jim Cramer.Martin Shkreli goes to war with CNBC - CNN Money
money.cnn.com/2015/10/23/media/martin-shkreli-cnbc-war/
Oct 23, 2015 - Martin Shkreli, the hedge fund manager who triggered an outcry by putting a 5,000% markup on its lifesaving drug, has gone to war with CNBC.Martin Shkreli: 5 Fast Facts You Need to Know | Heavy.com
heavy.com/.../martin-shkreli-hedge-fund-ceo-aids-drug-price-increase-tu...
Sep 21, 2015 - Martin Shkreli is the hedge fund investor who has increased the price of AIDS drug ... You can watch his appearance on CNBC below: ... Shkreli began his life in finance as a 17-year-old intern for Mad Money host Jim Cramerhttp://www.benzinga.com/news/15/11/6005468/why-is-martin-shkreli-no-longer-lending-out-his-kalobios-shares
Martin Shkreli has made quite a name for himself over the past couple months. On November 18, he made a 1.2 million share purchase of KaloBios Pharmaceuticals Inc KBIO 32.26%, a biopharma company focused on the development of monoclonal antibody therapeutics.
The penny stock company said just days before Shkreli's purchase that "it would wind down operations and liquidate assets, adding that any expectation of strategic alternatives were "highly unlikely." The company said it would discontinue two development programs, in Phase 1 and Phase 2 stage, adding it would not be able to file its Form 10-Q for the third quarter.".....
http://www.benzinga.com/news/15/11/6005468/why-is-martin-shkreli-no-longer-lending-out-his-kalobios-shares
Martin Shkreli has made quite a name for himself over the past couple months. On November 18, he made a 1.2 million share purchase of KaloBios Pharmaceuticals Inc KBIO 32.26%, a biopharma company focused on the development of monoclonal antibody therapeutics.
The penny stock company said just days before Shkreli's purchase that "it would wind down operations and liquidate assets, adding that any expectation of strategic alternatives were "highly unlikely." The company said it would discontinue two development programs, in Phase 1 and Phase 2 stage, adding it would not be able to file its Form 10-Q for the third quarter.".....
Read more: http://www.benzinga.com/news/15/11/6005468/why-is-martin-shkreli-no-longer-lending-out-his-kalobios-shares#ixzz3slA2pn90
Controversial drug CEO was accused of serious 'harassment'
www.cnbc.com/.../controversial-drug-ceo-was-accused-of-serious-harass...
Sep 22, 2015 - I will go to any length necessary to get it back," Shkreli allegedly wrote the wife of former Retrophin employee Timothy Pierotti in a January 2013 letter, according to court documents.Controversial drug CEO was accused of serious 'harassment'
Shkreli made headlines this week when it was revealed that his current company Turing Pharmaceuticals, had hiked the price of Daraprim from $13.50 to $750 per pill after Turing bought the drug, which is used to treat a parasitic infection, in August.
The move, which Shkreli has defended as necessary for Turing to be profitable and to fund research for a replacement drug, drew widespread criticism, with Clinton calling the move "outrageous." Clinton's comment, and her vow to introduce a plan to control drug prices overall, sent biotech stocks plummeting Monday.
Shkreli, a former hedge fund manager, had been fired from Retrophin, which he founded, last year. In August, the company sued him in Manhattan federal court, for "repeatedly breaching his duty of loyalty to Retrophin," by allegedly using his control of Retrophin to "enrich himself and to pay off claims of [his prior hedge fund's] investors (who he had defrauded)," Retrophin claimed in its suit.
"Shkreli was the paradigm faithless servant," Retrophin charged in its suit, which is seeking $65 million in damages from its founder.
Shkreli has denied Retrophin's claims, and has asked that the dispute be settled in arbitration. He told The New York Times that Retrophin owes him at least $25 million in severance, and that "they are sort of concocting this wild and crazy and unlikely story to swindle me out of the money."...............
While SEC 'Whistleblower' McKessey:Zionist Hedge Fund Pharmaceutical Money Launderer Price Gouger
Martin Shkreli Is CEO Of Illegal Pump And Dump Op Against Americans For Elite Offshore Clients
Martin Shkreli named KaloBios CEO - Business Insider
www.businessinsider.com/martin-shkreli-named-kalobios-ceo-2015-11
Nov 20, 2015 - Martin Shkreli is now the CEO of KaloBios after taking a big stake in the company on Wednesday.Martin Shkreli buys more than 50% stake in KaloBios ...
www.businessinsider.com/martin-shkreli-buys-50-stake-in-kalobios-201...
Nov 19, 2015 - Late Wednesday night, the pharmaceutical company KaloBios disclosed that an investor group involving Shkreli acquired more than half of the ...Drug stock soars 500% after Martin Shkreli buys it - Nov. 19 ...
money.cnn.com/2015/11/19/.../martin-shkreli-turing-kalobios-drug/
Nov 19, 2015 - KaloBios is a drug company that was going to shut down. But controversial pharma exec Martin Shkreli appears to be coming to the rescue. ... LOL!pump and dump, make a killing on the upside, followed by him having a rat ...KaloBios Pharmaceuticals, Inc. (KBIO) Appoints Martin ...
https://www.reddit.com/.../kalobios_pharmaceuticals_inc_kbio_appoints...
4 days ago - KaloBios Pharmaceuticals, Inc. (KBIO) Appoints Martin Shkreli as CEO ... This is likely nothing more than a pump and dump, albeit a very ...Martin Shkreli on Twitter: "Very excited to announce ...
https://twitter.com/martinshkreli/status/667562366847053824
Nov 19, 2015 - ... announce: KaloBios Pharmaceuticals, Inc. Appoints Martin ShkreliCEO and .... @MartinShkreli Classic pump-'n-dump move from a con man.What Martin Shkreli Sees In KaloBios Pharmaceuticals ...
www.forbes.com/.../what-martin-shkreli-sees-in-kalobios-pharmaceutical...
Nov 19, 2015 - For years, KaloBios Pharmaceuticals Inc. (NASDAQ:KBIO), a developer of monoclonal antibody therapeutics for the treatment of cancer, looked ...
Missing: pump dump
KaloBios soars 800% after Martin Shkreli takes control ...
www.marketwatch.com › Industries › Pharmaceuticals
Nov 18, 2015 - KaloBios shares KBIO, +30.79% soared more than 800% in late trading Wednesday, after Turing Pharmaceuticals CEO Martin Shkreli gained ...
Missing: pump dump
Martin Shkreli, major shareholder of KaloBios ... - Octafinance
www.octafinance.com/martin-shkreli-major-shareholder-of-kalobios-pha...
6 days ago - The Major Shareholder, Martin Shkreli just Purchased 440000 shares. ... Price Chart of Kalobios Pharmaceuticals NASDAQ:KBIO Stock .... China Margin Debt Hits 8-Week High, Japan Pumps'n'Dumps As Kyle Bass Fears ...Shorts Executed As KaloBios Goes Full Volkswagen: Here's ...
www.zerohedge.com/.../shorts-executed-kalobios-goes-full-volkswagen
4 days ago - Shorts Executed As KaloBios Goes Full Volkswagen: Here's Why ...Martin Shkreli (@MartinShkreli) November 23, 2015. Average: 5.Meet KaloBios, the Pharma Firm Up 4000% in Six Days ...
blogs.wsj.com/.../11/.../meet-kalobios-the-pharma-firm-up-4000-in-six-day...
4 days ago - Martin Shkreli, the chief executive of Turing Pharmaceuticals AG, had been ... Looks like a typical Boiler Room pump and dump scheme.
No comments:
Post a Comment